GRANTS AND INVESTORS

While we are currently involved in a Phase I clinical trial for Hemophilia A Patients with inhibitors https://clinicaltrials.gov/ct2/show/NCT03818763?term=Hematopoietic%2C+Hari&cond=Hemophilia+A&draw=2&rank=1

Platelet Targeted Therapeutics has a broad portfolio of products that we would love to move forward. Looking for donors / investors with an interest in serving  the rare disease community.